RPRX 13F position history: Pat Dorsey - Dorsey Asset Management
Royalty Pharma plc, as reported in Pat Dorsey - Dorsey Asset Management’s quarterly 13F filings. See all fund managers holding RPRX.
| Quarter | Activity | Shares | Value | % of portfolio | Reported price | |
|---|---|---|---|---|---|---|
| Q2 2026 | Added | 2,456,528 | $137,737,525 | 8.82% | $56.07 | Filing |
| Q1 2026 | Added | 2,276,570 | $109,207,063 | 8.70% | $47.97 | Filing |
| Q4 2025 | Trimmed | 2,259,469 | $87,305,882 | 7.59% | $38.64 | Filing |
| Q3 2025 | New | 2,350,449 | $82,923,841 | 7.45% | $35.28 | Filing |